Daniel Duncan

1.1k total citations
29 papers, 364 citations indexed

About

Daniel Duncan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Daniel Duncan has authored 29 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Daniel Duncan's work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (6 papers) and Acute Myeloid Leukemia Research (4 papers). Daniel Duncan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (6 papers) and Acute Myeloid Leukemia Research (4 papers). Daniel Duncan collaborates with scholars based in United States, Nepal and United Kingdom. Daniel Duncan's co-authors include Eric A. Severson, Leonardo De La Fuente, Fernando Navarrete, Paul A. Cobine, Shakti Ramkissoon, Douglas I. Lin, Jeffrey S. Ross, Jo‐Anne Vergilio, Ibrahim Ramzy and Richard S.P. Huang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Daniel Duncan

26 papers receiving 355 citations

Peers

Countries citing papers authored by Daniel Duncan

Since Specialization

Citations

This map shows the geographic impact of Daniel Duncan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Duncan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Duncan more than expected).

Fields of papers citing papers by Daniel Duncan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Duncan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Duncan. The network helps show where Daniel Duncan may publish in the future.

Co-authorship network of co-authors of Daniel Duncan

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Duncan. A scholar is included among the top collaborators of Daniel Duncan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Duncan. Daniel Duncan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predicting EGFR mutational status from pathology images using a real-world dataset 2023 ·Scientific Reports ·(unknown), (unknown), Daniel Duncan, Douglas I. Lin, Richard Davis, Richard S.P. Huang, Donna C. Ferguson, Tyler Janovitz, Matthew Hiemenz, (unknown), Erik Lehnert, Moran N. Cabili, Garrett M. Frampton, Priti S. Hegde, Lee A. Albacker	16
2	Comprehensive genomic profiling reveals molecular subsets of ASXL1 -mutated myeloid neoplasms 2023 ·Leukemia & lymphoma ·Steven M. Johnson, James Haberberger, Jonathan Galeotti, Lori Ramkissoon, Catherine C. Coombs, Daniel R. Richardson, Matthew C. Foster, Daniel Duncan, Nathan D. Montgomery, (unknown), Joshua F. Zeidner	1
3	Deletions on 9p21 are associated with worse outcomes after anti-PD-1/PD-L1 monotherapy but not chemoimmunotherapy 2022 ·npj Precision Oncology ·Ericka M. Ebot, Daniel Duncan, Khaled Tolba, David Fabrizio, Garrett M. Frampton, Leah A. Comment, Lee A. Albacker	15
4	Clinicopathologic and genomic characterization of PD-L1-positive uterine cervical carcinoma 2021 ·Modern Pathology ·Richard S.P. Huang, James Haberberger, Karthikeyan Murugesan, Natalie Danziger, Matthew Hiemenz, Eric A. Severson, Daniel Duncan, Shakti Ramkissoon, Jeffrey S. Ross, Julia A. Elvin, Douglas I. Lin	24
5	Comprehensive Genomic Characterization of ASXL1 C.1934dupG (p.G646fs12) Versus Other ASXL1* mutations in Myeloid Neoplasia 2021 ·Blood ·Steven M. Johnson, Lori Ramkissoon, James Haberberger, (unknown), Jonathan Galeotti, Daniel R. Richardson, Matthew C. Foster, Jeffrey Ross, Shakti Ramkissoon, Joshua F. Zeidner, Daniel Duncan, Nathan D. Montgomery	0
6	Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial Carcinomas 2021 ·The Oncologist ·Richard S.P. Huang, James Haberberger, (unknown), Eric A. Severson, Daniel Duncan, (unknown), Amanda Hemmerich, Claire Edgerly, Karthikeyan Murugesan, (unknown), (unknown), Oliver Holmes, Matthew Hiemenz, Jeffrey M. Venstrom, Julia A. Elvin, James Creeden, Douglas I. Lin, Jeffrey S. Ross, Shakti Ramkissoon	9
7	Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12 139 Cancer Patients 2021 ·Clinical Chemistry ·Richard S.P. Huang, (unknown), Dean C. Pavlick, (unknown), Lei Yang, Dexter X. Jin, Bernard J. Fendler, Eric A. Severson, Jonathan Keith Killian, Matthew Hiemenz, Daniel Duncan, Douglas I. Lin, Lucas Dennis, (unknown), Ole Gjoerup, (unknown), Jeffrey M. Venstrom, Julia A. Elvin, Shakti Ramkissoon, Jeffrey S. Ross	12
8	JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology 2021 ·The American Journal of Surgical Pathology ·Megan J. Fitzpatrick, Lucas R. Massoth, (unknown), Jo‐Anne Vergilio, Eric A. Severson, Daniel Duncan, Shakti Ramkissoon, Robert P. Hasserjian, Annette S. Kim, Aliyah R. Sohani, Erik A. Williams, Valentina Nardi	36
9	107P Immune Checkpoint Inhibitor (ICPI) resistance genes STK11 and KEAP1: A comparative Comprehensive Genomic Profiling (CGP) study 2020 ·Annals of Oncology ·(unknown), Ethan S. Sokol, Natalie Danziger, Dean C. Pavlick, Julia A. Elvin, J. Keith Killian, (unknown), (unknown), (unknown), Eric A. Severson, Amanda Hemmerich, Daniel Duncan, Claire Edgerly, (unknown), Matthew Hiemenz, Prasanth Reddy, (unknown), (unknown), Alexa B. Schrock, Jeffrey S. Ross	0
10	Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss 2020 ·Gynecologic Oncology ·Douglas I. Lin, Amanda Hemmerich, Claire Edgerly, Daniel Duncan, Eric A. Severson, Richard S.P. Huang, Shakti Ramkissoon, Yamicia Connor, Meghan Shea, Jonathan L. Hecht, Siraj M. Ali, Jo‐Anne Vergilio, Jeffrey S. Ross, Julia A. Elvin	40
11	PD-L1 expression, tumor mutational burden, and microsatellite instability status in 746 pancreas ductal adenocarcinomas. 2020 ·Journal of Clinical Oncology ·Amanda Hemmerich, Claire Edgerly, Daniel Duncan, (unknown), Natalie Danziger, Garrett M. Frampton, Julia A. Elvin, Jo‐Anne Vergilio, Jonathan Keith Killian, Douglas I. Lin, Erik A. Williams, Siraj M. Ali, Prasanth Reddy, Vincent A. Miller, (unknown), Charlotte A. Brown, Brian M. Alexander, Jeffrey S. Ross, Eric A. Severson, Shakti Ramkissoon	2
12	The impact of ERAS on development of acute kidney injury (AKI) in gynecologic oncology patients 2020 ·Gynecologic Oncology ·(unknown), Katherine L. Tucker, Daniel Duncan, Linda Van Le	1
13	Assessing Measurable Residual Disease in Acute Myeloid Leukemia 2019 ·Daniel Duncan, Joshua F. Zeidner, Nathan D. Montgomery	1
14	Comprehensive Genomic Profiling of 104 Rare Histiocytic and Dendritic Cell Neoplasms Reveals Shared and Distinct Targetable Genomic Alterations 2019 ·Blood ·Lucas R. Massoth, Yin P. Hung, Judith A. Ferry, Robert P. Hasserjian, Abner Louissaint, Meagan Montesion, Ethan S. Sokol, Dean C. Pavlick, (unknown), Natalie Danziger, Jonathan Keith Killian, Eric A. Severson, Daniel Duncan, Julia A. Elvin, Vincent A. Miller, Jeffrey S. Ross, Jo‐Anne Vergilio, Lawrence Zukerberg, Erik A. Williams	2
15	Loss of Heterozygosity of FLT3-ITD Is Common in Acute Myeloid Leukemia and May be a More Consistent Prognostic Marker Than FLT3-ITD Allele Frequency 2019 ·Blood ·Eric A. Severson, Ethan Sokol, Russell W. Madison, Daniel Duncan, Amanda Hemmerich, Claire Edgerly, (unknown), Nicholas Britt, Jo‐Anne Vergilio, Julia A. Elvin, Prasanth Reddy, Pratheesh Sathyan, Brian M. Alexander, Jeffrey S. Ross, Siraj M. Ali, Shakti Ramkissoon	1
16	Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns 2016 ·Laboratory Investigation ·Amanda L. Treece, Daniel Duncan, Weihua Tang, Sandra Elmore, Douglas R. Morgan, Ricardo L. Domínguez, Olga Speck, Michael O. Meyers, Margaret L. Gulley	41
17	Xylella fastidiosa Differentially Accumulates Mineral Elements in Biofilm and Planktonic Cells 2013 ·PLoS ONE ·Paul A. Cobine, (unknown), Fernando Navarrete, Daniel Duncan, (unknown), Leonardo De La Fuente	58
18	Displaced Granulosa Cells in the Fallopian Tube Mistaken for Metastatic Granulosa Cell Tumor 2012 ·International Journal of Gynecological Pathology ·Daniel Duncan, (unknown), Ruth A. Lininger, (unknown)	6
19	Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay 2012 ·Clinical Biochemistry ·Steven W. Cotten, Daniel Duncan, (unknown), Carl Seashore, Catherine A. Hammett‐Stabler	25
20	Argentaffin Carcinoma of Ileum with Raised Serum 5-Hydroxytryptamine 1955 ·BMJ ·Daniel Duncan, (unknown), J. L. Gibbons	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact